The Centre for Medical Parasitology (CMP) at the University of Copenhagen/Rigshospitalet has recently expanded its research capabilities with the purchase of an Attana Cell 200 system.
CMP is focused on malaria research, covering a wide range of disciplines from laboratory research in Copenhagen to applied field studies in Africa. Major current research topics include drug resistance, experimental parasitology, immunology, parasite biology, pathogenesis and vaccine development. CMP has employed its Attana A100 instrument since 2008 in its vaccine development project, which has already resulted in several scientific publications and a PhD thesis. With the addition of the Attana Cell 200 system, CMP will enable a wider range of studies, including biologically important cell based assays.
“We have been working with Attana systems for more than five years here at CMP and are very pleased with both the capacity of the systems and the service and support that Attana provides. We recently engaged Attana CRO services to verify cell assays, and the positive outcome led us to purchase an Attana Cell 200 system of our own,” says Prof Ali Salanti, director of research at CMP.
